Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Enhabit
EHAB
Enhabit
US Home Health Demand And Value-Based Care Will Create Future Opportunities
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
29 May 25
Updated
24 Jul 25
1
Set Fair Value
0
votes
Share
AnalystConsensusTarget
's Fair Value
US$10.25
23.9% undervalued
intrinsic discount
24 Jul
US$7.80
Loading
1Y
-8.5%
7D
16.1%
Author's Valuation
US$10.3
23.9% undervalued
intrinsic discount
AnalystConsensusTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystConsensusTarget Fair Value
US$10.3
23.9% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-158m
1b
2019
2021
2023
2025
2027
2028
Revenue US$1.2b
Earnings US$27.3m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
5.56%
Healthcare Services revenue growth rate
0.30%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.95%
Calculation
US$27.34m
Earnings '28
x
23.79x
PE Ratio '28
=
US$650.43m
Market Cap '28
US$650.43m
Market Cap '28
/
51.71m
No. shares '28
=
US$12.58
Share Price '28
US$12.58
Share Price '28
Discounted to 2025 @ 7.56% p.a.
=
US$10.11
Fair Value '25